Mymetics Corp (MYMX)

[Work Harder]

The non-human primate study received financial support from REACTing, the ANR (AM-CoV-Path), and the European Infrastructure TRANSVAC2 (730964). The funders had no role in study design, data
collection, data analysis, data interpretation, or data reporting.

https://www.cell.com/cell/pdf/S0092-8674(21)00078-7.pdf

AM-COV-Path aims at the development of a non-human primate model of the SArS-CoV-2 infection and disease.

Project coordinator

Mr. Roger Le Grand (French Atomic Energy and Alternative Energies Commission)

Partner

INSERM INSERM / Infection, Antimicrobials, Modeling, Evolution

https://translate.google.com/translate?hl=en&sl=fr&u=https://anr.fr/Projet-ANR-20-COVI-0021&prev=search&pto=aue

SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota

https://www.tandfonline.com/doi/full/10.1080/19490976.2021.1893113

HS, RLG, and FT obtained funding (ANR/FRM AM-CoV-Path and ANR ACROBAT)